These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31883350)

  • 1. New approach to identify colistin-resistant Pseudomonas aeruginosa by high-resolution melting curve analysis assay.
    Tahmasebi H; Dehbashi S; Arabestani MR
    Lett Appl Microbiol; 2020 Apr; 70(4):290-299. PubMed ID: 31883350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-harboring of mcr-1 and β-lactamase genes in Pseudomonas aeruginosa by high-resolution melting curve analysis (HRMA): Molecular typing of superbug strains in bloodstream infections (BSI).
    Tahmasebi H; Dehbashi S; Arabestani MR
    Infect Genet Evol; 2020 Nov; 85():104518. PubMed ID: 32891877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Molecular Typing of Colistin-Resistant
    Tahmasebi H; Dehbashi S; Arabestani MR
    Infect Drug Resist; 2020; 13():2943-2955. PubMed ID: 32922046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of PmrA and PmrB genes in colistin-resistant Pseudomonas aeruginosa strains via PCR method.
    Heidari L; Sepahvand S; Darvishi M; Jafari R
    Pak J Pharm Sci; 2019 May; 32(3 (Supplementary)):1175-1177. PubMed ID: 31303587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid-mediated mcr-1 gene in Acinetobacter baumannii and Pseudomonas aeruginosa: first report from Pakistan.
    Hameed F; Khan MA; Muhammad H; Sarwar T; Bilal H; Rehman TU
    Rev Soc Bras Med Trop; 2019 Sep; 52():e20190237. PubMed ID: 31508785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of nonclonal Pseudomonas aeruginosa isolates with reduced colistin susceptibility in Korea.
    Lee JY; Song JH; Ko KS
    Microb Drug Resist; 2011 Jun; 17(2):299-304. PubMed ID: 21381965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa.
    Di X; Wang R; Liu B; Zhang X; Ni W; Wang J; Liang B; Cai Y; Liu Y
    J Antibiot (Tokyo); 2015 Sep; 68(9):551-5. PubMed ID: 25805069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic variations between colistin-susceptible and -resistant Pseudomonas aeruginosa clinical isolates and their effects on colistin resistance.
    Lee JY; Na IY; Park YK; Ko KS
    J Antimicrob Chemother; 2014 May; 69(5):1248-56. PubMed ID: 24474431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment.
    Valenza G; Radike K; Schoen C; Horn S; Oesterlein A; Frosch M; Abele-Horn M; Hebestreit H
    Scand J Infect Dis; 2010 Dec; 42(11-12):885-9. PubMed ID: 20735333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
    Mohanty S; Maurya V; Gaind R; Deb M
    J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of Pseudomonas aeruginosa isolates resistant to all antimicrobial agents, but susceptible to colistin, in Daegu, Korea.
    Lee YC; Ahn BJ; Jin JS; Kim JU; Lee SH; Song DY; Lee WK; Lee JC
    J Microbiol; 2007 Aug; 45(4):358-63. PubMed ID: 17846591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of colistin resistance in Pseudomonas aeruginosa ST235 clone in South Korea.
    Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
    Int J Antimicrob Agents; 2017 Jun; 49(6):767-769. PubMed ID: 28392440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates.
    Lee JY; Ko KS
    Diagn Microbiol Infect Dis; 2014 Mar; 78(3):271-6. PubMed ID: 24412662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomally Encoded
    Snesrud E; Maybank R; Kwak YI; Jones AR; Hinkle MK; McGann P
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of colistin resistance in pmrA-, phoP-, parR- and cprR-inactivated mutants of Pseudomonas aeruginosa.
    Lee JY; Chung ES; Na IY; Kim H; Shin D; Ko KS
    J Antimicrob Chemother; 2014 Nov; 69(11):2966-71. PubMed ID: 24994873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.
    Kohlenberg A; Weitzel-Kage D; van der Linden P; Sohr D; Vögeler S; Kola A; Halle E; Rüden H; Weist K
    J Hosp Infect; 2010 Apr; 74(4):350-7. PubMed ID: 20170982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions.
    Kolpen M; Appeldorff CF; Brandt S; Mousavi N; Kragh KN; Aydogan S; Uppal HA; Bjarnsholt T; Ciofu O; Høiby N; Jensen PØ
    Pathog Dis; 2016 Feb; 74(1):ftv086. PubMed ID: 26458402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Resolution Melting as a rapid, reliable, accurate and cost-effective emerging tool for genotyping pathogenic bacteria and enhancing molecular epidemiological surveillance: a comprehensive review of the literature.
    Tamburro M; Ripabelli G
    Ann Ig; 2017; 29(4):293-316. PubMed ID: 28569339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients.
    Adachi JA; Perego C; Graviss L; Dvorak T; Hachem R; Chemaly RF; Raad II
    Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.